Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN
Conditions
Hepatocellular Carcinoma (HCC) · Intrahepatic Cholangiocarcinoma (Icc) · Neuroendocrine Tumors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU de Nantes, Nantes, France
AP-HP - Site de Beaujon, Paris, France